MBX Biosciences Names New CEO and CFO as Shares Drop After-Hours
MBX Biosciences announced that Executive Chairman Steve Hoerter will assume the roles of Chairman and Chief Executive Officer immediately, replacing Kent Hawryluk, who resigned as President, CEO and board member. The company also named John Smither, interim CFO since March 2026, as its permanent Chief Financial Officer. Shares fell 8.3% in after-ho…